Athersys gains $640k from MS Society to advance stem cell candidate
This article was originally published in Clinica
Executive Summary
Athersys, a Cleveland, Ohio-based company working on non-embryonic stem cell preparations, has entered into a partnership with the National Multiple Sclerosis Society to develop its Multistem investigational stem cell candidate for the treatment of multiple sclerosis.